Organovo Holdings Inc (ONVO)
0.9349
-0.05
(-5.08%)
USD |
NASDAQ |
May 10, 16:00
0.96
+0.03
(+2.68%)
After-Hours: 20:00
Organovo Holdings Cash from Operations (TTM): -16.72M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -16.72M |
September 30, 2023 | -16.24M |
June 30, 2023 | -15.30M |
March 31, 2023 | -12.41M |
December 31, 2022 | -9.216M |
September 30, 2022 | -9.528M |
June 30, 2022 | -9.454M |
March 31, 2022 | -8.453M |
December 31, 2021 | -9.026M |
September 30, 2021 | -7.161M |
June 30, 2021 | -12.17M |
March 31, 2021 | -13.32M |
December 31, 2020 | -14.42M |
September 30, 2020 | -13.51M |
June 30, 2020 | -11.52M |
March 31, 2020 | -14.88M |
December 31, 2019 | -16.75M |
September 30, 2019 | -20.12M |
June 30, 2019 | -19.29M |
March 31, 2019 | -20.38M |
December 31, 2018 | -20.91M |
September 30, 2018 | -23.40M |
June 30, 2018 | -25.23M |
March 31, 2018 | -28.86M |
December 31, 2017 | -30.47M |
Date | Value |
---|---|
September 30, 2017 | -31.08M |
June 30, 2017 | -31.30M |
March 31, 2017 | -29.18M |
December 31, 2016 | -29.49M |
September 30, 2016 | -29.36M |
June 30, 2016 | -31.61M |
March 31, 2016 | -29.37M |
December 31, 2015 | -27.45M |
September 30, 2015 | -24.84M |
June 30, 2015 | -22.53M |
March 31, 2015 | -19.60M |
December 31, 2014 | -19.39M |
September 30, 2014 | -18.98M |
June 30, 2014 | -16.26M |
March 31, 2014 | -15.56M |
December 31, 2013 | -12.14M |
September 30, 2013 | -10.53M |
June 30, 2013 | -8.800M |
December 31, 2012 | -9.693M |
September 30, 2012 | -7.724M |
June 30, 2012 | -5.425M |
March 31, 2012 | -3.596M |
December 31, 2011 | -0.0713M |
September 30, 2011 | -0.0878M |
June 30, 2011 | -0.1094M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-20.12M
Minimum
Sep 2019
-7.161M
Maximum
Sep 2021
-13.13M
Average
-13.32M
Median
Mar 2021
Cash from Operations (TTM) Benchmarks
Marinus Pharmaceuticals Inc | -118.00M |
Cartesian Therapeutics Inc | -51.16M |
Adial Pharmaceuticals Inc | -6.807M |
Longeveron Inc | -19.00M |
Viracta Therapeutics Inc | -39.89M |